CSPC Pharma (01093) spent HK $29.8096 million to repurchase 6.44 million shares on September 17th.
Shiyao Group (01093) announced that the company spent HK$2980.96 million on September 17, 2024...
CSPC PHARMA (01093) announced that the company repurchased 6.44 million shares for a total of 29.8096 million Hong Kong dollars on September 17, 2024, with a buyback price of 4.58-4.66 Hong Kong dollars per share.
Related Articles
Galaxy Securities: Anti-involution policy trend continues, space photovoltaic industry accelerates.
Galaxy Securities: Continuous Innovation in Mainstream Consumer Goods, the Future of Wearable Products is Promising.
Zhongtai: How to interpret the market reaching new highs at the beginning of the year?
Galaxy Securities: Anti-involution policy trend continues, space photovoltaic industry accelerates.
Galaxy Securities: Continuous Innovation in Mainstream Consumer Goods, the Future of Wearable Products is Promising.
Zhongtai: How to interpret the market reaching new highs at the beginning of the year?
RECOMMEND
Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026
Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026
“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026
